Squarepoint Ops LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$488,619
-55.7%
41,798
-37.2%
0.00%
-75.0%
Q1 2023$1,103,996
+82.5%
66,586
-25.5%
0.00%
+100.0%
Q4 2021$605,000
+73.4%
89,336
+17.9%
0.00%0.0%
Q1 2021$349,000
+2.0%
75,781
-26.0%
0.00%
-33.3%
Q4 2020$342,000
+79.1%
102,356
+59.3%
0.00%0.0%
Q3 2020$191,000
-79.9%
64,257
-74.0%
0.00%
-87.5%
Q1 2020$952,000
-74.7%
247,194
-75.4%
0.02%
+9.1%
Q4 2019$3,765,000
+4789.6%
1,004,042
+6813.5%
0.02%
+2100.0%
Q3 2019$77,000
-50.6%
14,523
-64.1%
0.00%
-50.0%
Q2 2019$156,000
+79.3%
40,500
-10.3%
0.00%
+100.0%
Q4 2018$87,000
-86.2%
45,147
-77.6%
0.00%
-87.5%
Q2 2018$629,000
+104.9%
201,450
+56.8%
0.01%
+60.0%
Q1 2018$307,000
-57.9%
128,500
-31.2%
0.01%
-61.5%
Q4 2017$730,000
+276.3%
186,643
+142.7%
0.01%
+225.0%
Q3 2017$194,000
+16.2%
76,900
+27.1%
0.00%
+33.3%
Q2 2017$167,000
+778.9%
60,500
+236.1%
0.00%
+200.0%
Q4 2016$19,000
-34.5%
18,000
-56.5%
0.00%
-50.0%
Q2 2016$29,00041,4000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders